At HYGEIA Group, we are committed to boosting the long-term economic value and healthy growth of the Group companies. Our high ethics and principles determine our business progress and reflect our relationships with the stakeholders and groups that are directly or indirectly affected by the Group’s business activities.
Business Ethics and Corporate Governance are extremely significant, since we believe that proper implementation of the Corporate Governance Principles, as well as the provisions of the Code of Medical and Scientific Ethics and Conduct, are pivotal not only for improving the performance of the Group’s assets and its development, but also for gaining the trust of investors, the medical community and patients.
We not only aspire to strictly adhere to the legislative provisions with regard to the mandatory regulations for Corporate Governance, but to also adopt principles and values that ensure the growth of the Company.
Mainly aspiring to strictly adhere to the legislative provisions with regard to the mandatory regulations for Corporate Governance, but also to adopt principles and values that ensure the growth of the Company, by following contemporary management practices, HYGEIA Group has incorporated a Corporate Governance Code to its operations. The Code was drafted taking into account the Corporate Governance Code for listed companies, drawn up by the Hellenic Federation of Enterprises (SEV), along with the widely accepted Corporate Governance principles that apply in the EU Member States.
Meanwhile, the Group implements a Financial Risk Management Policy, which identifies the multiple risks the Group is exposed to, including market risk, liquidity risk, credit risk and currency risk. The Group’s risk management program aims to limit the negative impact on financial results arising from the weakness to forecast financial market trends and the fluctuations in cost and sales variables.